Full-Time

Health Economic Policy and Reimbursement Analyst

Posted on 5/22/2025

Deadline 5/28/25
Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

No salary listed

Junior, Mid

Madrid, Spain

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Minimum of 2 years of relevant experience, or advanced degree with no prior experience
  • Knowledge of the development, application and review of health economic models
  • Experience in the development of value propositions
  • Good knowledge of the reimbursement systems across Western Europe
  • Ability to work independently and part of a wider multi-functional team
  • Ability to negotiate and influence across functions, businesses and systems
  • Ability to travel when needed for up to 20% of working time
  • Excellent oral and written communication skills, ability to work across cultures, strong project management skills, results orientation, quality orientation
Responsibilities
  • Creates and executes comprehensive market access strategies through the integration of pricing and reimbursement, health technology assessment, evidence-based medicine review, and health economic modelling activities
  • Designs, develops and implements an integrated approach to all aspects of the payer value proposition from early development through and beyond loss of exclusivity
  • Communicates the unique attributes of the therapeutic area drugs/medical devices to external multi-stakeholders to ensure the drug's/device's value proposition will be recognized and maximize market uptake
  • Works collectively with payers, including HTA, reimbursement influencers and other decision makers to ensure the continuous changing reimbursement systems remain fair to all involved parties
  • Develops strategic studies with the end-customer in mind to ensure that the results will favourably impact pricing, reimbursement and market access as well as market uptake
  • Conducts quantitative and qualitative pricing research
  • Works with Health Economics/Outcomes Research to design pricing strategy

Medtronic provides medical technology, services, and solutions to improve patient care across various health conditions. The company develops and manufactures a wide range of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. Medtronic's products are used by hospitals, clinics, and healthcare professionals worldwide. What sets Medtronic apart from its competitors is its strong focus on research and development, allowing it to continuously innovate and introduce new products to the market. The company's goal is to enhance patient outcomes and reduce healthcare costs by offering comprehensive solutions that include not only medical devices but also training and support for healthcare providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for remote patient monitoring aligns with Medtronic's partnership with Corsano Health.
  • Growing interest in wearable devices supports Medtronic's distribution agreement for Corsano's wearable.
  • The trend towards personalized medicine benefits Medtronic's neurostimulation and diabetes management technologies.

What critics are saying

  • Voluntary recall of ventilators due to patient death may harm Medtronic's reputation.
  • Spin-off of Diabetes business into MiniMed may cause operational disruptions.
  • Partnership with Corsano Health may face integration and execution challenges.

What makes Medtronic unique

  • Medtronic is a global leader in medical technology with operations in over 150 countries.
  • The company offers a comprehensive suite of products and services for various medical conditions.
  • Medtronic invests heavily in R&D to innovate and bring new products to market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Medical Device Network
Jun 13th, 2025
FDA tags Medtronic's voluntary ventilator recall as Class I after patient death

Medtronic has announced a voluntary recall of select Newport HT70 and Newport HT70 Plus ventilators and certain related service parts for the devices.

Hit Consultant
Jun 13th, 2025
Medtronic Rebrands Diabetes Business As ā€œMinimedā€ Ahead Of Spin-Off

Medtronic Rebrands Diabetes Business as ā€œMiniMedā€ Ahead of Spin-Off. by Jasmine Pennic 06/13/2025 Leave a Comment. What You Should Know: – Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company’s roots, reflecting its original name prior to its acquisition by Medtronic in 2001 and its deep, 40-year history of transforming diabetes care worldwide.The announcement marks a significant step in the intended separation of Medtronic’s Diabetes business into a new, independent entity.Simplify Life with DiabetesThe new MiniMed’s mission is to make diabetes more predictable so that everyone can embrace life to the fullest. The company aims to address the constant mental and physical demands required to keep glucose levels in a healthy range, developing technology that helps push the daily burden of diabetes management into the background.Based in Northridge, California, the Diabetes business consists of a passionate team of more than 8,000 employees. Medtronic is targeting the completion of the planned separation within 18 months of its initial announcement, subject to customary conditions and legal requirements.ā€œOur journey began in 1983, when visionary entrepreneur Alfred E

The Healthcare Technology Report
Jun 9th, 2025
Medtronic to Spin Off Its Diabetes Business into an Independent Company

Medtronic expects to execute the separation through an initial public offering followed by a split-off transaction.

Horoekareading
Jun 2nd, 2025
The Top 5 Medical Device Animation Video Companies

Ghost Productions has worked with some of the biggest names in the medical device industry, including Medtronic, Boston Scientific, and Johnson & Johnson.

Siam News
May 23rd, 2025
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference

GALWAY, Ireland, May 24, 2025 /PRNewswire/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025.

INACTIVE